ASPS on Medicare Part B Drug ProposalDecember 12
CMS offered opportunities to reduce costs for Medicare Part B prescription drugs, but ASPS and other medical specialty groups voice concern over the impact of the proposal.
After implementing a multi-year targeted lobbying campaign, ASPS has secured passage of the BCPEA. The passage of this bill is a huge victory for patients facing a breast cancer diagnosis. Read More